Biological Effects of Anti-RANKL Antibody and Zoledronic Acid on Growth and Tooth Eruption in Growing Mice

The anti-bone resorptive drugs denosumab, an anti-human-RANKL antibody, and zoledronic acid (ZOL), a nitrogen-containing bisphosphonate, have recently been applied for treatment of pediatric patients with bone diseases, though details regarding their effects in growing children have yet to be fully...

Descripción completa

Detalles Bibliográficos
Autores principales: Isawa, Motoki, Karakawa, Akiko, Sakai, Nobuhiro, Nishina, Saki, Kuritani, Miku, Chatani, Masahiro, Negishi-Koga, Takako, Sato, Masashi, Inoue, Mitsuko, Shimada, Yukie, Takami, Masamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934544/
https://www.ncbi.nlm.nih.gov/pubmed/31882595
http://dx.doi.org/10.1038/s41598-019-56151-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934544/
https://www.ncbi.nlm.nih.gov/pubmed/31882595
http://dx.doi.org/10.1038/s41598-019-56151-1

Ejemplares similares